SECURITIES PURCHASE AND EXCHANGE AGREEMENTSecurities Purchase and Exchange Agreement • January 14th, 2020 • Interpace Biosciences, Inc. • Surgical & medical instruments & apparatus • Delaware
This Securities Purchase and Exchange Agreement (this “Agreement”) is dated as of January 10, 2020, by and among Interpace Biosciences, Inc., a Delaware corporation (the “Company”), 1315 Capital II, L.P., a Delaware limited partnership (including its successors and assigns, “1315 Capital”) and Ampersand 2018 Limited Partnership, a Delaware limited partnership (including its successors and assigns, “Ampersand” and, together with 1315 Capital, the “Purchasers” and each a “Purchaser”).
